David A. Siegel Tff Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.86 - $9.65 $106,330 - $149,575
-15,500 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.21 - $10.49 $30,282 - $44,058
-4,200 Reduced 21.32%
15,500 $120,000
Q2 2021

Aug 16, 2021
BUY
$8.48 - $13.61 $53,424 - $85,743
6,300 Added 47.01%
19,700 $189,000
Q1 2021

May 17, 2021
BUY
$12.96 - $19.75 $173,664 - $264,650
13,400 New
13,400 $182,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0
View Full List

About TFF Pharmaceuticals, Inc.

TFFP Quotes by TradingView
  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.66M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email